Sattva Sukun Lifecare has scheduled a board meeting for June 29, 2026, to consider the regularization of two directors and propose alterations to its Memorandum of Association. The meeting will be held at the company's registered office in Kandivali West, Mumbai, to discuss key governance and structural changes requiring shareholder consent.

The board will consider the regularization of Mr. Sachin Bhanubhai Manseta as a Non-Executive, Independent Director and Mr. Chirag Dedhia as a Non-Executive - Non Independent Director. Additionally, the directors will evaluate proposals to alter the Object Clause and Clause I (Name Clause) of the Memorandum of Association. These changes are subject to the approval of shareholders and other regulatory or statutory authorities.

Agenda Items

The meeting agenda includes the following specific matters:

• Regularization of Mr. Sachin Bhanubhai Manseta (DIN: 03471126) as Non-Executive, Independent Director.
• Regularization of Mr. Chirag Dedhia (DIN: 08583331) as Non-Executive - Non Independent Director.
• Proposal for alteration of the Object Clause of the Memorandum of Association.
• Proposal for alteration of Clause I (Name Clause) of the Memorandum of Association.
• Consideration and approval of the Notice for an Extra Ordinary General Meeting (EGM).
• Appointment of a Scrutinizer to conduct the remote e-voting and voting process for the EGM.

The intimation was submitted to BSE Ltd. on June 24, 2026, pursuant to Regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE Limited. The results were published in Mumbai Lakshadweep (Marathi) and Active Times (English) in compliance with Regulation 47(l)(a) of the SEBI (LODR) Regulations, 2015. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss of ₹56.97 lakh in the quarter ended March 31, 2026.

The Board approved the financial results at a meeting held on June 4, 2026, which was rescheduled from May 30, 2026, to complete the audit process. M/s. SSRV & Associates, the statutory auditors, issued an unmodified opinion on the financial statements. Total income from operations for the year stood at ₹423.70 lakh, a decrease from ₹566.69 lakh in the previous year. For the quarter, total income was ₹33.41 lakh compared to ₹131.51 lakh in the corresponding period of the previous year.

Financial Performance

The company reported a profit before tax of ₹2.92 lakh for FY26, significantly lower than ₹318.78 lakh in FY25. Total expenses for the year increased to ₹420.78 lakh from ₹247.91 lakh in the previous year. The basic earnings per share (EPS) for FY26 was ₹0.00, compared to ₹0.13 in the previous year.

Rights Issue Utilization

During the financial year 2025-26, the company allotted 19,16,01,248 equity shares on a rights issue basis, raising ₹19.16 crore. The funds were utilized for working capital, business expansion, and investment in subsidiaries. The company confirmed there was no deviation in the use of funds raised.

Trading Window Closure

The trading window for designated persons and their immediate relatives remains closed. The window closed on April 01, 2026, and will reopen 48 hours after the conclusion of the Board Meeting, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE280E01038/403ed9a6-2f51-487d-840a-2be9d23fcd23.pdf